BioSpace News Archive

Mannatech, Incorporated today announced financial results for its second quarter of 2022.

GreenLight Biosciences today announced a private placement of approximately $109 million.

Soligenix, Inc. announced today its recent accomplishments and financial results for the quarter ended June 30, 2022.

Crinetics Pharmaceuticals today reported financial results for the second quarter ended June 30, 2022.

RELIEF THERAPEUTICS Holding SA and Acer Therapeutics Inc. (Nasdaq: ACER) (Acer), today announced that the European Commission has granted orphan medicinal product designation in the EU to ACER-001 (sodium phenylbutyrate) for the potential treatment of patients with Maple Syrup Urine Disease (MSUD).

Palisade Bio today announced the pricing of an underwritten public offering for gross proceeds of approximately $12 million prior to deducting underwriting discounts and commissions and offering expenses.

Biofrontera Inc. announced today financial results for the three and six months ended June 30, 2022 and provided a business update.

Royal Philips (NYSE: PHG, AEX: PHIA), today announced an important milestone in the evolving standard of care for treating patients with peripheral vascular disease (PVD): the establishment of the first-ever global consensus for the appropriate use of intravascular ultrasound (IVUS) in lower extremity arterial and venous interventions.

Therapeutic Solutions International announced today new data demonstrating superior effects of the Company’s ApoptoCyte™ procedure treated JadiCell™ product compared to other stem cells in treating an animal model of Chronic Obstructive Pulmonary Disease (COPD).

StageZero Life Sciences announced that it will release its second quarter operational and financial results before the markets open on Tuesday, August 16, 2022.